These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9737371)

  • 1. Karyology and tumorigenicity testing requirements: past, present and future.
    Petricciani JC; Horaud FN
    Dev Biol Stand; 1998; 93():5-13. PubMed ID: 9737371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal characterization of MRC-5 cell banks utilizing G-banding technique.
    Rosolowsky M; McKee R; Nichols W; Garfinkle B
    Dev Biol Stand; 1998; 93():109-17. PubMed ID: 9737385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and control of live oral poliovirus vaccine in WI-38 human diploid cells.
    Stones PB
    Dev Biol Stand; 1976 Dec 13-15; 37():251-3. PubMed ID: 1036401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous cell substrate considerations.
    Lubiniecki AS
    Bioprocess Technol; 1990; 10():495-513. PubMed ID: 1370028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell substrates: where do we stand after 50 years of discussion?
    Petricciani J
    Dev Biol (Basel); 2006; 123():11-21; discussion 55-73. PubMed ID: 16566432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell line issues: historical and future perspectives.
    Petricciani JC
    Dev Biol Stand; 1992; 76():5-11. PubMed ID: 1478355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cells, science and health.
    Petricciani JC
    Dev Biol Stand; 1989; 70():3-10. PubMed ID: 2668074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell substrates: lessons learned and challenges remaining.
    Petricciani JC
    Dev Biol Stand; 1999; 100():57-63. PubMed ID: 10616176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Karyology: vaccine manufacturers' views.
    von Seefried A; Walton MJ; MacMorine HG
    Dev Biol Stand; 1976 Dec 13-15; 37():169-75. PubMed ID: 801470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing issues of quality control: diploid and non-diploid cell lines.
    Pearson J
    Dev Biol Stand; 1992; 76():13-7. PubMed ID: 1478333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematically experimental investigation on carcinogenesis or tumorigenicity of VERO cell lines of different karyotypes in nude mice in vivo used for viral vaccine manufacture.
    Zhang DL; Ji L; Li LJ; Huang GS
    Yi Chuan Xue Bao; 2004 Jul; 31(7):647-60. PubMed ID: 15473315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.